CA Stock MarketDetailed Quotes

Cosciens Biopharma Inc (CSCI)

Watchlist
  • 2.480
  • -0.210-7.81%
15min DelayMarket Closed Apr 14 16:00 ET
7.90MMarket Cap-0.55P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cosciens Biopharma Inc (CSCI) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
-21.79%7.5M
-46.84%1.77M
-20.74%1.48M
17.63%2.75M
-27.08%1.5M
34.22%9.59M
173.64%3.32M
-4.15%1.87M
67.89%2.34M
-20.39%2.06M
Operating revenue
-21.79%7.5M
-46.84%1.77M
-20.74%1.48M
17.63%2.75M
-27.08%1.5M
34.22%9.59M
173.64%3.32M
-4.15%1.87M
67.89%2.34M
-20.39%2.06M
Cost of revenue
-0.14%4.85M
-9.11%1.16M
-5.69%862K
16.93%1.78M
-8.33%1.06M
15.53%4.86M
19.42%1.27M
-20.31%914K
155.13%1.52M
-17.44%1.15M
Gross profit
-44.03%2.65M
-70.28%609K
-35.11%621K
18.93%974K
-51.00%443K
60.96%4.73M
1,284.46%2.05M
18.88%957K
2.76%819K
-23.86%904K
Operating expense
-30.61%13.01M
-47.04%3M
-54.62%2.63M
-27.26%3.33M
49.37%4.06M
147.81%18.75M
159.11%5.66M
202.24%5.79M
139.35%4.57M
74.79%2.72M
Selling and administrative expenses
-3.69%10.06M
-12.67%2.4M
-29.78%2.1M
-13.37%2.64M
76.69%2.93M
89.04%10.45M
62.01%2.75M
102.16%2.99M
149.51%3.04M
46.44%1.66M
-Selling and marketing expense
----
----
----
----
----
----
----
----
----
-44.20%3.37K
-General and administrative expense
-3.69%10.06M
-12.67%2.4M
-29.78%2.1M
----
----
89.04%10.45M
62.01%2.75M
102.16%2.99M
----
46.69%1.65M
Research and development costs
-64.47%2.95M
-79.44%599K
-81.17%527K
-54.90%690K
6.78%1.13M
307.06%8.3M
495.71%2.91M
541.97%2.8M
121.42%1.53M
150.39%1.06M
Operating profit
26.09%-10.37M
33.85%-2.39M
58.48%-2.01M
37.34%-2.35M
-99.39%-3.62M
-202.94%-14.02M
-77.31%-3.61M
-335.10%-4.83M
-237.07%-3.76M
-393.22%-1.81M
Net non-operating interest income (expenses)
-63.14%115K
-96.00%5K
-92.55%14K
-1.64%60K
1,000.00%36K
505.19%312K
247.22%125K
917.39%188K
354.17%61K
93.91%-4K
Non-operating interest income
-35.83%283K
-75.00%37K
-72.86%57K
0.00%83K
79.66%106K
647.46%441K
--148K
--210K
--83K
--59K
Non-operating interest expense
30.23%168K
39.13%32K
95.45%43K
4.55%23K
11.11%70K
-5.15%129K
0.00%23K
-4.35%22K
-8.33%22K
152.11%63K
Total other finance cost
----
----
----
----
----
----
----
----
----
0.10%40.7K
Other net income (expenses)
93.53%-98K
109.70%210K
114.25%174K
-122.64%-407K
-1,580.00%-74K
-550.60%-1.51M
-2,947.37%-2.16M
-936.30%-1.22M
4,081.40%1.8M
-92.95%5K
Gain on sale of security
-93.08%183K
-69.15%195K
123.96%486K
-123.42%-415K
-428.00%-82K
11,120.83%2.65M
--632K
--217K
--1.77M
233.22%25K
Special income (charges)
92.58%-316K
--0
78.34%-316K
----
----
---4.26M
---2.8M
---1.46M
----
----
-Less:Impairment of capital assets
-94.36%240K
--0
-83.55%240K
----
----
--4.26M
--2.8M
--1.46M
----
----
-Less:Write off
--76K
--0
--76K
----
----
--0
--0
--0
----
----
Other non-operating income (expenses)
-64.29%35K
650.00%15K
-80.95%4K
-69.23%8K
140.00%8K
-72.78%98K
-98.00%2K
-85.62%21K
-39.53%26K
-122.31%-20K
Income before tax
32.03%-10.35M
61.53%-2.17M
69.00%-1.82M
-42.41%-2.7M
-101.60%-3.66M
-248.40%-15.23M
-193.61%-5.65M
-493.83%-5.87M
-73.15%-1.9M
-400.06%-1.81M
Income tax
-88.10%10K
-99.08%10K
0
100.21%1K
0
109.49%84K
400.56%1.08M
47.17%-112K
-101.70%-474K
-428.98%-412K
Earnings from equity interest net of tax
Net income
32.34%-10.36M
67.57%-2.18M
68.39%-1.82M
-89.94%-2.7M
-160.89%-3.66M
-339.28%-15.31M
-330.37%-6.73M
-641.62%-5.76M
-65.35%-1.42M
-392.14%-1.4M
Net income continuous operations
32.34%-10.36M
67.57%-2.18M
68.39%-1.82M
-89.94%-2.7M
-160.89%-3.66M
-339.28%-15.31M
-330.37%-6.73M
-641.62%-5.76M
-65.35%-1.42M
-392.14%-1.4M
Noncontrolling interests
Net income attributable to the company
32.34%-10.36M
67.57%-2.18M
68.39%-1.82M
-89.94%-2.7M
-160.89%-3.66M
-339.28%-15.31M
-330.37%-6.73M
-641.62%-5.76M
-65.35%-1.42M
-392.14%-1.4M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
32.34%-10.36M
67.57%-2.18M
68.39%-1.82M
-89.94%-2.7M
-160.89%-3.66M
-339.28%-15.31M
-330.37%-6.73M
-641.62%-5.76M
-65.35%-1.42M
-392.14%-1.4M
Diluted earnings per share
44.86%-3.27
71.06%-0.68
69.19%-0.57
-32.81%-0.85
-52.63%-1.16
-213.76%-5.93
-176.47%-2.35
-340.48%-1.85
-36.17%-0.64
-393.03%-0.76
Basic earnings per share
44.86%-3.27
71.06%-0.68
69.19%-0.57
-32.81%-0.85
-52.63%-1.16
-213.76%-5.93
-176.47%-2.35
-340.48%-1.85
-36.17%-0.64
-393.03%-0.76
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue -21.79%7.5M-46.84%1.77M-20.74%1.48M17.63%2.75M-27.08%1.5M34.22%9.59M173.64%3.32M-4.15%1.87M67.89%2.34M-20.39%2.06M
Operating revenue -21.79%7.5M-46.84%1.77M-20.74%1.48M17.63%2.75M-27.08%1.5M34.22%9.59M173.64%3.32M-4.15%1.87M67.89%2.34M-20.39%2.06M
Cost of revenue -0.14%4.85M-9.11%1.16M-5.69%862K16.93%1.78M-8.33%1.06M15.53%4.86M19.42%1.27M-20.31%914K155.13%1.52M-17.44%1.15M
Gross profit -44.03%2.65M-70.28%609K-35.11%621K18.93%974K-51.00%443K60.96%4.73M1,284.46%2.05M18.88%957K2.76%819K-23.86%904K
Operating expense -30.61%13.01M-47.04%3M-54.62%2.63M-27.26%3.33M49.37%4.06M147.81%18.75M159.11%5.66M202.24%5.79M139.35%4.57M74.79%2.72M
Selling and administrative expenses -3.69%10.06M-12.67%2.4M-29.78%2.1M-13.37%2.64M76.69%2.93M89.04%10.45M62.01%2.75M102.16%2.99M149.51%3.04M46.44%1.66M
-Selling and marketing expense -------------------------------------44.20%3.37K
-General and administrative expense -3.69%10.06M-12.67%2.4M-29.78%2.1M--------89.04%10.45M62.01%2.75M102.16%2.99M----46.69%1.65M
Research and development costs -64.47%2.95M-79.44%599K-81.17%527K-54.90%690K6.78%1.13M307.06%8.3M495.71%2.91M541.97%2.8M121.42%1.53M150.39%1.06M
Operating profit 26.09%-10.37M33.85%-2.39M58.48%-2.01M37.34%-2.35M-99.39%-3.62M-202.94%-14.02M-77.31%-3.61M-335.10%-4.83M-237.07%-3.76M-393.22%-1.81M
Net non-operating interest income (expenses) -63.14%115K-96.00%5K-92.55%14K-1.64%60K1,000.00%36K505.19%312K247.22%125K917.39%188K354.17%61K93.91%-4K
Non-operating interest income -35.83%283K-75.00%37K-72.86%57K0.00%83K79.66%106K647.46%441K--148K--210K--83K--59K
Non-operating interest expense 30.23%168K39.13%32K95.45%43K4.55%23K11.11%70K-5.15%129K0.00%23K-4.35%22K-8.33%22K152.11%63K
Total other finance cost ------------------------------------0.10%40.7K
Other net income (expenses) 93.53%-98K109.70%210K114.25%174K-122.64%-407K-1,580.00%-74K-550.60%-1.51M-2,947.37%-2.16M-936.30%-1.22M4,081.40%1.8M-92.95%5K
Gain on sale of security -93.08%183K-69.15%195K123.96%486K-123.42%-415K-428.00%-82K11,120.83%2.65M--632K--217K--1.77M233.22%25K
Special income (charges) 92.58%-316K--078.34%-316K-----------4.26M---2.8M---1.46M--------
-Less:Impairment of capital assets -94.36%240K--0-83.55%240K----------4.26M--2.8M--1.46M--------
-Less:Write off --76K--0--76K----------0--0--0--------
Other non-operating income (expenses) -64.29%35K650.00%15K-80.95%4K-69.23%8K140.00%8K-72.78%98K-98.00%2K-85.62%21K-39.53%26K-122.31%-20K
Income before tax 32.03%-10.35M61.53%-2.17M69.00%-1.82M-42.41%-2.7M-101.60%-3.66M-248.40%-15.23M-193.61%-5.65M-493.83%-5.87M-73.15%-1.9M-400.06%-1.81M
Income tax -88.10%10K-99.08%10K0100.21%1K0109.49%84K400.56%1.08M47.17%-112K-101.70%-474K-428.98%-412K
Earnings from equity interest net of tax
Net income 32.34%-10.36M67.57%-2.18M68.39%-1.82M-89.94%-2.7M-160.89%-3.66M-339.28%-15.31M-330.37%-6.73M-641.62%-5.76M-65.35%-1.42M-392.14%-1.4M
Net income continuous operations 32.34%-10.36M67.57%-2.18M68.39%-1.82M-89.94%-2.7M-160.89%-3.66M-339.28%-15.31M-330.37%-6.73M-641.62%-5.76M-65.35%-1.42M-392.14%-1.4M
Noncontrolling interests
Net income attributable to the company 32.34%-10.36M67.57%-2.18M68.39%-1.82M-89.94%-2.7M-160.89%-3.66M-339.28%-15.31M-330.37%-6.73M-641.62%-5.76M-65.35%-1.42M-392.14%-1.4M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 32.34%-10.36M67.57%-2.18M68.39%-1.82M-89.94%-2.7M-160.89%-3.66M-339.28%-15.31M-330.37%-6.73M-641.62%-5.76M-65.35%-1.42M-392.14%-1.4M
Diluted earnings per share 44.86%-3.2771.06%-0.6869.19%-0.57-32.81%-0.85-52.63%-1.16-213.76%-5.93-176.47%-2.35-340.48%-1.85-36.17%-0.64-393.03%-0.76
Basic earnings per share 44.86%-3.2771.06%-0.6869.19%-0.57-32.81%-0.85-52.63%-1.16-213.76%-5.93-176.47%-2.35-340.48%-1.85-36.17%-0.64-393.03%-0.76
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 -0.47%
Sample Name
Sample Code
 -4.55%
Sample Name
Sample Code
 -6.72%
4
SHANGHAI PECHEM
00338
-7.75%
5
SINO OIL & GAS
00702
-12.82%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +22.83%
Sample Name
Sample Code
 +16.64%
Sample Name
Sample Code
 +15.87%
4
Hangzhou Shunwang Technology
300113
+10.25%
5
Ucloud Technology Co., Ltd
688158
+9.33%
View More
Middle East conflict spreads to the stock market! How should investors respond?
US President Trump stated in a recent interview that the US war with Iran has 'ended.' According to Axios, Pakistan, Egypt, and Turkey have Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -